Articles
The Initial Recognition and Diagnosis of Dementia

https://doi.org/10.1016/S0002-9343(98)00022-9Get rights and content

Abstract

Dementia is characterized by a decline in cognition, behavioral disturbances, and interference with daily functioning and independence. Diagnosis is sometimes delayed as patients or family members often misattribute obvious manifestations of cognitive decline to normal aging rather than to the onset of a degenerative disease. Many physicians do not perform mental status examinations or do not use them effectively to detect early symptoms. Clinical markers are available to decrease the difficulty in distinguishing dementia from depression and confusional states such as delirium. Alzheimer’s disease (AD) is the most common form of dementia; others include rapidly progressive dementias, dementias associated with strokes and Parkinson’s disease, and frontotemporal dementias. Often, AD coexists with other forms of dementia. Sensitivity to early warning signs, interviews with family members, and mental status examinations are essential to early detection of AD, and will prove useful to primary-care physicians who care for older patients.

Section snippets

Recognizing dementia

The most difficult aspect of the diagnosis of dementia is recognizing that the patient is experiencing lapses in cognition. There are barriers to the detection of dementia in routine practice.3., 4. Rarely do patients seek medical attention for the symptoms of dementia. Lack of insight on the part of the patient is a common early feature. Family members usually seek out medical attention. However, family members are often tardy in recognizing that the changes in the affected individuals

Aging

Memory problems in the elderly are blamed most often on normal aging. The alleged inevitability of impaired memory with aging creates a ready explanation for cognitive lapses. Two decades of research in cognitive psychology has established that normal aging is not associated with dramatic declines in recent memory or judgment.8 The interpretation of what is expected in cognitive aging is complicated by methodologic challenges. The elderly are more likely to have concurrent illnesses that can

The differential diagnosis of dementia

The differential diagnosis of dementia in the elderly involves 5 major syndromes (Table 1)that encompass the commonly encountered presentations of subacute- or gradual-onset cognitive impairment. This scheme does not apply to the differential diagnosis of dementia in younger patients (individuals 45–50 years old). In younger patients, there are a number of diseases that must be considered that will not be discussed here.

Alzheimer’s disease: the prototypical dementia

Alzheimer’s disease (AD) is the most common form of dementia in the elderly. Approximately 60–80% of dementia patients in epidemiologic studies have AD.16., 17., 18., 19., 20., 21., 22.The Diagnostic and Statistical Manual of Mental Disorders, Fourth edition (DSM-IV) criteria for AD1., 23.(Table 2)require impairment of recent memory and at least one other cognitive or behavioral abnormality. The DSM-IV criteria refer to the additional deficits as aphasia, apraxia, and agnosia. However, these

Rapidly progressive dementias

Rapidly progressive dementias are the disorders of cognitive dysfunction in which symptoms and signs are present for only a few days or months (Table 4). Within this category are the dementias termed “treatable” in earlier diagnostic schemes. Metabolic and toxic disturbances are the most common of this group.30 A thorough history aimed at identifying antecedents and associated symptoms of the disorders listed in Table 4 will often provide the most accurate indication of the correct diagnosis.

Dementias associated with stroke

Vascular dementia is a controversial diagnosis. Because of the complexity of establishing the causal links between cerebral infarctions of various sizes and locations, neuropathologists vary in how they diagnose it. Furthermore, the presence of some AD pathology in most cases of vascular dementia raises the issue of what constitutes the minimal burden of AD changes necessary to make that diagnosis. Depending upon the degree of AD pathology, the contribution of vascular lesions to the dementia

Dementias associated with Parkinsonism

Extrapyramidal signs, which are often referred to collectively as Parkinsonism, are very common in the elderly.42 In roughly 30% of individuals with Parkinsonism, dementia will develop.43 The proportion of patients with Parkinson’s disease who are cognitively impaired is likely to be underrecognized because of the overwhelming problems with motor disturbances. Recognition of dementia in Parkinson’s disease is important because management and treatment issues are different from those for AD.

The

Frontotemporal dementias

The frontotemporal dementias (FTD) are much less common than either AD, vascular dementia, or dementia associated with Parkinsonism. It is diagnosed on the basis of historical and mental status examination evidence of disproportionate impairment of reasoning and judgment relative to anterograde amnesia (amnesia occurring after a trauma or disease).50 The term “dysexecutive syndrome” has been applied to the cognitive syndrome of patients with FTD who have grossly disturbed abstract reasoning,

Progressive aphasia

Patients with primary progressive aphasia are often misdiagnosed as having suffered from silent stroke. Alternatively, they are simply labeled as having AD, to the chagrin of families who see how different their relatives are from AD patients. The distinctive features of progressive aphasia, in contrast to AD, are the relative excess of dysfunction of expressive language and the relative paucity of anterograde amnesia.53 There is almost always an initial element of nonfluency. This takes the

Signs and symptoms of dementia by history and mental status examination in differential diagnosis

The assessment of a suspected dementia patient revolves around basic history and mental status examination techniques. There is no widely used history-taking instrument for dementia. Table 9covers the major areas of impairment to be reviewed with a relative or friend of the patient. A knowledgeable informant who can speak candidly about these topics is essential for establishing a diagnosis. Often, the queries in Table 9 are best discussed with the patient absent; the informants may not be

The neurologic examination

The remainder of the neurologic examination other than mental status is necessary mainly for differentiating vascular dementia and dementia associated with Parkinsonism from AD. The neurologic examination in a patient with vascular dementia may be unremarkable or there may be signs of hemiparesis, hemianesthesia, hemianopia, unilateral neglect, diplopia, dysphagia, dysarthria, facial palsy, ptosis, or pupillary abnormalities. None of these occurs exclusively in stroke, however, so that the

Laboratory diagnostic assessment

The American Academy of Neurology guidelines62 for the diagnosis of dementia make a number of specific recommendations (Table 11). The role of imaging studies is hotly debated.63., 64. Although neuroimaging is not routinely recommended, there are instances for its consideration for practicing physicians. The presence of other neurologic signs or symptoms (headaches, seizures, and abnormal motor exam findings), together with cognitive impairment, should prompt an imaging study. The importance of

Conclusions

Early recognition of dementia requires a high index of suspicion, necessary time to interview family members, and skill in assessing mental status. The differential diagnosis of dementia first requires eliminating depression and acute confusional states as principal diagnoses. Rapidly evolving dementias, vascular dementias, and dementias associated with Parkinsonism are the major categories to be distinguished from AD. In most primary-care settings, AD will be the most common etiologic

References (64)

  • E Kokmen et al.

    Epidemiology of dementia in Rochester, Minnesota

    Mayo Clin Proc

    (1996)
  • S.I Kramer et al.

    Depression, dementia and reversible dementia

    Clin Geriatr Med

    (1992)
  • M.F Folstein et al.

    Mini-mental state

    J Psychiatr Res

    (1975)
  • American Psychiatric Association Diagnostic and Statistical Manual

    (1994)
  • J.L Cummings et al.
  • C.M Callahan et al.

    Documentation and evaluation of cognitive impairment in elderly primary care patients

    Ann Intern Med

    (1995)
  • G.W Ross et al.

    Frequency and characteristics of silent dementia among elderly Japanese-American men

    JAMA

    (1997)
  • D.L Bachman et al.

    Incidence of dementia and probable Alzheimer’s disease in a general populationthe Framingham study

    Neurology

    (1993)
  • L.E Hebert et al.

    Age-specific incidence of Alzheimer’s disease in a community population

    JAMA

    (1995)
  • K Schaie

    The hazards of cognitive aging

    The Gerontologist

    (1989)
  • K Schaie

    Perceptual speed in adulthoodCross-sectional and longitudinal studies

    Psychology and Aging

    (1989)
  • R.C Petersen et al.

    Memory function in normal aging

    Neurology

    (1992)
  • J Francis et al.

    A prospective study of delirium in hospitalized elderly

    JAMA

    (1990)
  • A.M Murray et al.

    Acute delirium and functional decline in the hospitalized elderly patient

    J Gerontology

    (1993)
  • A LaRue

    Patterns of performance on the Fuld object memory evaluation in elderly inpatients with depression or dementia

    J Clin Exp Neuropsychol

    (1989)
  • M.A Raskind et al.

    Fluphenazine enanthate in the outpatient treatment of late paraphrenia

    J Am Geriatr Soc

    (1979)
  • D.L Bachman et al.

    Prevalence of dementia and probable senile dementia of the Alzheimer type in the Framingham study

    Neurology

    (1992)
  • Canadian study of health and agingstudy methods and prevalence of dementia

    Can Med Assoc J

    (1994)
  • D.A Evans et al.

    Prevalence of Alzheimer’s disease in a community population of older persons. Higher than previously reported

    JAMA

    (1989)
  • M.F Folstein et al.

    Dementiacase ascertainment in a community survey

    J Gerontol

    (1991)
  • H.C Hendrie et al.

    Prevalence of Alzheimer’s disease and dementia in two communitiesNigerian Africans and African Americans

    Am J Psychiatry

    (1995)
  • E Kokmen et al.

    Prevalence of medically diagnosed dementia in a defined United States populationRochester, Minnesota, January 1, 1975

    Neurology

    (1989)
  • L White et al.

    Prevalence of dementia in older Japanese-American men in Hawaii

    JAMA

    (1996)
  • G McKhann et al.

    Clinical diagnosis of Alzheimer’s diseasereport of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease

    Neurology

    (1984)
  • Costa PT, Williams TF, Somerfield M, et al. Early Identification of Alzheimer’s Disease and Related Dementias....
  • R.C Petersen et al.

    Apolipoprotein E status as a predictor of the development of Alzheimer’s disease in memory-impaired individuals

    JAMA

    (1995)
  • M Gearing et al.

    The consortium to establish a registry for Alzheimer’s Disease (CERAD). Part X. Neuropathology confirmation of the clinical diagnosis of Alzheimer’s disease

    Neurology

    (1995)
  • R Motter et al.

    Reduction of b-amyloid peptide 42 in the cerebrospinal fluid of patients with Alzheimer’s disease

    Ann Neurol

    (1995)
  • Statement on use of Apolipoprotein E testing for Alzheimer disease

    JAMA

    (1995)
  • Apolipoprotein E genotyping in Alzheimer disease: Position statement of the National Institute on Aging/Alzheimer...
  • A.M Clarfield

    The reversible dementiasdo they reverse?

    Ann Intern Med

    (1988)
  • E Alexander et al.

    Do surgical brain lesions present as isolated dementia? A population-based study

    J Am Ger Soc

    (1995)
  • Cited by (60)

    • BRAIM: A computer-aided diagnosis system for neurodegenerative diseases and brain lesion monitoring from volumetric analyses

      2017, Computer Methods and Programs in Biomedicine
      Citation Excerpt :

      Besides the physiological aging and natural cognitive decline, numerous diseases such as Parkinson disease, Multiple Sclerosis, and many common processes in the adult population (i.e. infections, neoplasms, systemic diseases, drug consumption, etc.) can adversely affect cognitive functions both acute or chronically [1,2]. Regardless etiology, in all cases an early diagnosis is crucial to proceed with appropriate therapeutic measures in order to improve patients quality of life and/or moderate the development of clinical complications [3–5]. In the clinical setting, recent studies have highlighted the relevance of performing volumetric measurements instead of the classical approach of qualitative analyses.

    • Early development of social deficits in APP and APP-PS1 mice

      2012, Neurobiology of Aging
      Citation Excerpt :

      Hence, there is an increasing need to find additional behavioral markers of AD pathology, which may be more reliable and accurate in modeling the disease progression in genetic mouse models than the cognitive deficits (Chung and Cummings, 2000). In particular, identifying AD-like behavioral abnormalities already at the early stages of AD pathology, i.e., before extensive plaque deposition, is of critical importance for testing the efficacy of potential early pharmacological and nonpharmacological treatments (Knopman, 1998). For all these reasons, growing attention has recently been devoted to the noncognitive characterization of genetic mouse models of AD, focusing on those behavioral alterations which may parallel specific symptoms observed in AD patients.

    • New diagnoses of dementia among older patients admitted to postacute care

      2010, Journal of the American Medical Directors Association
      Citation Excerpt :

      Interestingly, this association was not found in a study in assisted living facilities4 and has been inconsistently observed in studies conducted among community-dwelling and primary care older populations,8,11,12,27 but has also been reported in a study among acute medical inpatients.28 Most likely, underrecognition in the oldest-old patients relates to the still widespread belief of a normal age-related decline in mental performances.29 In addition, these patients might also be at increased risk for underrecognition because the usual barriers to diagnosis might seem especially relevant to physicians caring for these frail patients.

    • The geriatric assessment

      2011, American Family Physician
    View all citing articles on Scopus
    View full text